Mental disorders are the mega-trend that place a heavy burden on politics, healthcare providers and the economy. There is a strong demand for better, cheaper and more objective diagnostic tools. The products and services by HBImed AG enable the more objective diagnosis of mental disorders and contribute to a goal-oriented, personalized therapy. The analysis tools and reference databases created by HBImedAG are unique in terms of scope and precision.
HBImed AG was founded in 2009 in Switzerland to convert 25 years of brain research and clinical application with biomarkers and a reference database which was developed during this time into clinically applicable products:
Database-based analysis software
Dr. Andreas Müller
President of the board of directors
Director of the Research Clinic, Chur, Switzerland, CEO Brain and Trauma Foundation, Switzerland, President of the board of directors of HBImed AG
Prof. Dr. Juri Kropotov
Director of Laboratory of the Institute of the Human Brain (HBI) of Russian Academy of Sciences, St. Petersburg
Professor, The Norwegian University of Science and Technology (NTNU), Trondheim, Norway
Chief scientist at HBImed AG
Dr. Bernhard Wandernoth
HBImed AG is independent so far, self-financed and is run by its three founders Prof. J. Kropotov (research), A. Müller, Ph.D. (clinical application) and B. Wandernoth, Ph.D. (signal processing).